Telomir Pharmaceuticals, Inc. Common Stock Financial Flexibility Index
Telomir Pharmaceuticals, Inc. Common Stock financial flexibility index. Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Financial Flexibility Index of -2.14x as of March 2026. Free cash flow of $-1.77 Million (operating CF $-1.77 Million minus capex $0.00) represents -2% of total liabilities ($827.31K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Telomir Pharmaceuticals, Inc. Common Stock (2021–2025)
Financial flexibility index of Telomir Pharmaceuticals, Inc. Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for Telomir Pharmaceuticals, Inc. Common Stock across 5 annual periods. Explore Telomir Pharmaceuticals, Inc. Common Sto (TELO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Telomir Pharmaceuticals, Inc. Common Stock Financial Flexibility Index by Year (2021–2025)
Telomir Pharmaceuticals, Inc. Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Telomir Pharmaceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see Telomir Pharmaceuticals, Inc. Common Sto (TELO) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.58x | $-3.69 Million | $-3.69 Million | $1.43 Million | ▲ +65.3% |
| 2024 | -7.45x | $-5.07 Million | $-5.07 Million | $680.97K | ▼ -157.6% |
| 2023 | -2.89x | $-3.86 Million | $-3.86 Million | $1.34 Million | ▼ -508.0% |
| 2022 | -0.48x | $-468.66K | $-468.66K | $986.01K | ▲ +45.0% |
| 2021 | -0.86x | $-119.39K | $-119.40K | $138.13K | — |